"}

BV-6 TFA salt - Moligand™, ≥98% , CAS No.1001600-56-1(freebase)

In stock
SKU
B413788
Grouped product items
Product Name Qty
[B413788-5mg] BV-6 TFA salt (5mg)
€92.76
[B413788-25mg] BV-6 TFA salt (25mg)
€264.57
[B413788-50mg] BV-6 TFA salt (50mg)
€396.47
[B413788-100mg] BV-6 TFA salt (100mg)
€607.33

XIAP Selective Inhibitors | Antagonists

Information

BV-6 is a SMAC mimetic, dualcIAPandXIAPinhibitor.


Targets

cIAP ; XIAP


In vitro

BV6 inhibits the cell viability of HCC193 NSCLC cells with IC50 of 7.2 μM, induces apoptosis in both HCC193 and H460 cell lines, and also significantly enhances the radiosensitivity of these cell lines through activation of cleaved caspase-8 and cleaved caspase-9, respectively. In immature dendritic cells, BV-6 treatment results in moderate activation of the classical NF-kB pathway. Furthermore, BV-6 increases CIK cell-mediated lysis of hematological (H9, THP-1, and Tanoue) and solid malignancies (RH1, RH30, and TE671). BV-6 also enhances apoptosis of peripheral blood mononuclear cells and most notably has an inhibitory effect on immune cells limiting their cytotoxic potential.


Cell Research(from reference)

Cell lines:HCC193 and H460 cells 

Concentrations:~30 μM 

Incubation Time:~48 hours 

More Information

More Information
CAS1001600-56-1(freebase)
SynonymsN,N'-(hexane-1,6-diyl)bis(1-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-L-prolyl-beta-phenyl-L-phenylalaninamide):trifluoroacetic acid(1:x)
Specifications & PurityMoligand™, ≥98%
StorageStore at -20°C
Shipped InIce chest + Ice pads
Product Description

Information

BV-6 is a SMAC mimetic, dualcIAPandXIAPinhibitor.


Targets

cIAP ; XIAP


In vitro

BV6 inhibits the cell viability of HCC193 NSCLC cells with IC50 of 7.2 μM, induces apoptosis in both HCC193 and H460 cell lines, and also significantly enhances the radiosensitivity of these cell lines through activation of cleaved caspase-8 and cleaved caspase-9, respectively. In immature dendritic cells, BV-6 treatment results in moderate activation of the classical NF-kB pathway. Furthermore, BV-6 increases CIK cell-mediated lysis of hematological (H9, THP-1, and Tanoue) and solid malignancies (RH1, RH30, and TE671). BV-6 also enhances apoptosis of peripheral blood mononuclear cells and most notably has an inhibitory effect on immune cells limiting their cytotoxic potential.


Cell Research(from reference)

Cell lines:HCC193 and H460 cells 

Concentrations:~30 μM 

Incubation Time:~48 hours 

Pubchem Sid488200364
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488200364
SolubilitySolubility (25°C) In vitro DMSO: 100 mg/mL (82.94 mM); Water: 100 mg/mL (82.94 mM); Ethanol: 100 mg/mL warmed with 50ºC Water: bath (82.94 mM);
TargetXIAP

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.

Copyright © 2023-present Aladdin Scientific Corp All rights reserved.